| abstract |
The present invention provides for the treatment of pain, including pain caused by an inflammatory disease such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by inflammatory diseases (eg Corticosteroid microparticle conjugates that are caused by osteoarthritis or rheumatoid arthritis to damage the joints and/or tissues surrounding the joints. The corticosteroid microparticle blend is administered topically in a sustained release dosage form (with or without an immediate release component) which produces a clinically inconspicuous or ineffective ability to produce endogenous cortisol The effect of measuring the effects. |